2013

An international team of researchers working in the Boston and Singapore labs of Harvard Stem Cell Institute (HSCI) Blood Program leader Daniel Tenen, MD, recently identified new candidates for the treatment of an acute myeloid leukemia (AML) subtype...

Harvard stem cell scientists have found that cells known primarily for tempering immune response also exist in injured muscle tissue, an unexpected role for regulatory T cells. Regulatory T cells, or Tregs for short, accumulate in the skeletal muscles of...

Harvard stem cell scientists have discovered that the clump of cells that gives rise to the embryonic heart also contains cells that form the heart’s plumbing, such as the aorta and the other great vessels. While the discovery was made serendipitously by...

Harvard Stem Cell researchers and collaborators have shown that they can grow unlimited quantities of intestinal stem cells, then stimulate them to develop into nearly pure populations of different types of mature intestinal cells. Using these cells...

Harvard stem cell researchers have successfully coaxed stem cells to become kidney tubular cells, a significant advance toward one day using regenerative medicine, rather than dialysis and transplantation, to treat kidney failure. The findings are...

HSCI Principal Faculty member and Cancer Program leader Benjamin Ebert, MD, discusses the development of an animal model that allows scientists to test many possible leukemia drugs at a time, increasing the odds of finding one that eliminates cancer cells...

HSCI Executive Committee member Lee Rubin is one of seven scientists selected by biotech leader Biogen Idec to identify and develop new approaches for treating amyotrophic lateral sclerosis (ALS) - more commonly known as Lou Gehrig's disease. Rubin and...

A new finding by Harvard stem cell biologists turns one of the basics of neurobiology on its head by demonstrating that it is possible to turn one type of already differentiated neuron into another within the brain. The discovery by Paola Arlotta and...

The New York Stem Cell Foundation has announced the 2013 RFA for Innovator Awards for Early Career Investigators in Translational Stem Cell Research, and for the first time, is open to researchers at accredited academic institutions from throughout the...